(LONN) Lonza - Performance 16.2% in 12m
Compare LONN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
13.48%
#29 in Group
Rel. Strength
71.17%
#2302 in Universe
Total Return 12m
16.20%
#44 in Group
Total Return 5y
38.65%
#32 in Group
P/E 60.7
91th Percentile in Group
P/E Forward 31.7
79th Percentile in Group
PEG 1.15
88th Percentile in Group
FCF Yield -0.34%
82th Percentile in Group
12m Total Return: LONN (16.2%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: LONN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for LONN
Total Return (including Dividends) | LONN | XBI | S&P 500 |
---|---|---|---|
1 Month | 8.56% | 2.28% | -0.87% |
3 Months | 1.13% | -10.48% | -7.58% |
12 Months | 16.20% | -1.83% | 11.88% |
5 Years | 38.65% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | LONN | XBI | S&P 500 |
1 Month | 69.6% | 56.6% | 23% |
3 Months | -68.5% | -89.3% | -88.5% |
12 Months | 59.3% | -42.4% | 55.1% |
5 Years | -30.5% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #88 | 6.14% | 9.51% |
3 Month | #48 | 13.0% | 9.43% |
12 Month | #46 | 18.4% | 3.87% |
5 Years | #32 | 58.9% | -34.1% |
FAQs
Does LONN Lonza outperforms the market?
Yes,
over the last 12 months LONN made 16.20%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months LONN made 1.13%, while XBI made -10.48%.
Over the last 3 months LONN made 1.13%, while XBI made -10.48%.
Performance Comparison LONN vs Indeces and Sectors
LONN vs. Indices LONN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.16% | 9.43% | 12.4% | 4.32% |
US NASDAQ 100 | QQQ | 0.13% | 7.16% | 11.9% | 3.53% |
US Dow Jones Industrial 30 | DIA | 2.10% | 11.7% | 12.5% | 7.0% |
German DAX 40 | DAX | 2.39% | 7.24% | -7.15% | -8.48% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.12% | 11.4% | 15.4% | 10.2% |
Hongkong Hang Seng | HSI | 2.15% | 8.50% | 10.5% | 2.31% |
India NIFTY 50 | INDA | 4.0% | 4.50% | 12.1% | 13.1% |
Brasil Bovespa | EWZ | 1.96% | 3.96% | 8.67% | 22.0% |
LONN vs. Sectors LONN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 0.91% | 9.61% | 6.24% | -7.76% |
Consumer Discretionary | XLY | 1.08% | 8.66% | 9.86% | 2.88% |
Consumer Staples | XLP | 4.66% | 8.36% | 7.06% | 5.0% |
Energy | XLE | 5.64% | 22.4% | 18.2% | 27.3% |
Financial | XLF | 2.55% | 10.7% | 4.77% | -6.49% |
Health Care | XLV | 1.24% | 12.4% | 14.1% | 14.5% |
Industrial | XLI | 0.74% | 8.45% | 11.7% | 6.61% |
Materials | XLB | 1.77% | 11.0% | 19.8% | 19.7% |
Real Estate | XLRE | 2.68% | 9.87% | 13.3% | -1.89% |
Technology | XLK | -1.29% | 6.87% | 15.7% | 8.47% |
Utilities | XLU | 4.0% | 8.50% | 10.3% | -5.63% |
Aerospace & Defense | XAR | 0.21% | 2.17% | -1.16% | -10.4% |
Biotech | XBI | -0.14% | 6.28% | 25.0% | 18.0% |
Homebuilder | XHB | 1.85% | 10.8% | 27.2% | 23.2% |
Retail | XRT | 2.73% | 9.12% | 17.9% | 18.9% |